USD10
PVLA Shares
About Palvella TherapeuticsPalvella Therapeutics Inc is a clinical-stage biopharmaceutical company whose vision is to become the rare disease biopharmaceutical company focused on developing and commercializing novel therapies to treat patients suffering from serious, rare skin diseases and vascular malformations for which there are no FDA-approved therapies. Its product candidate, QTORIN 3.9% rapamycin anhydrous gel, is currently in clinical development for microcystic lymphatic malformations and cutaneous venous malformations. It operates in single segment.
USD10
PVLA Shares
About Palvella TherapeuticsPalvella Therapeutics Inc is a clinical-stage biopharmaceutical company whose vision is to become the rare disease biopharmaceutical company focused on developing and commercializing novel therapies to treat patients suffering from serious, rare skin diseases and vascular malformations for which there are no FDA-approved therapies. Its product candidate, QTORIN 3.9% rapamycin anhydrous gel, is currently in clinical development for microcystic lymphatic malformations and cutaneous venous malformations. It operates in single segment.
Stats
TRADING WINDOW
Closed
OPENS AT
Not enough data
MARKET CAP
$2.26B
OPEN PRICE
$146.61
LOW (1Y)
$29.59
HIGH (1Y)
$161.38
LOW (24H)
$145.79
HIGH (24H)
$158.08
VOLUME (24H)
$258.34K
4.9%
Price history
Time | Price | Change |
|---|---|---|
Today | $146.61 | |
1 Day | $150.72 | |
1 Week | $144.94 | |
1 Month | $114.21 | |
1 Year | $31.00 |
Past performance is not a reliable indicator of future results.
Discover more
Explore other stocks
Popular cryptocurrencies
Popular price predictions
Legal
Information is provided for informational purposes only, and is not investment advice. This is not an invitation, inducement or recommendation to buy any particular asset, or to employ any particular investment strategy. Coinbase makes no representation as to the accuracy, suitability or validity of any information provided.All ticker names are trademarks of their respective holders. Any ticker reference does not imply affiliate with or endorsement by a third-party. Real-time prices are sourced from third parties, but not from all markets. Source: Nasdaq Last Sale. Morningstar data ©2026.